The Most Studied Peptides for Recovery
Recovery is the most common reason people arrive at peptides after the metabolic family. This guide walks through the recovery family in plain language: what each compound is studied for, why the pairing exists, and how to approach it thoughtfully.
The Short Answer
- BPC-157 is the most frequently cited compound in the recovery and repair research family.
- TB-500 is studied alongside BPC-157 and is supplied by Polaris Research as a blended vial.
- KPV and Thymosin Alpha 1 sit in the same broad research family and are supplied as separate 10mg vials.
- Every recovery-family vial ships with a batch-specific Certificate of Analysis.
BPC-157, the tissue-signalling peptide
BPC-157 is a pentadecapeptide studied in animal and cell models for tendon, ligament, soft-tissue, and gut-signalling pathways. It is the single most discussed peptide in research circles for tissue-repair contexts, and the compound most often reached for after the demands of training or injury.
It is studied for how it speaks to tissue-repair signalling and angiogenesis, the formation of new blood vessels that supports repair, which is why it sits at the centre of the recovery family.
| Compound | Vial | Price | Price per mg | Purity |
|---|---|---|---|---|
| BPC-157 10mg | 10mg · LYO | $89 | $8.90/mg | ≥99.4% |
| BPC-157 + TB-500 10mg | 10mg · LYO | $139 | $13.90/mg | ≥99.3% |
| KPV 10mg | 10mg · LYO | $89 | $8.90/mg | ≥99.5% |
| Thymosin Alpha 1 10mg | 10mg · LYO | $199 | $19.90/mg | ≥99.2% |
TB-500, the recovery-context peptide
TB-500 is studied alongside BPC-157 for recovery contexts. Where BPC-157 is studied for tissue-signalling pathways, TB-500 is studied for the broader recovery context that surrounds repair. The two are paired because they speak to different sides of the same goal rather than pulling redundantly on one pathway.
That complementarity is the test of any sound pairing: if you can explain why two compounds belong together, the pairing reasons. If you cannot, that is your answer. Our Art of Pairing guide covers the principle in depth.
Approaching recovery thoughtfully
Recovery peptides are approached with the same patience as every signalling compound: tissue repair works with the body's own timelines, never against them. The foundations, sleep, protein, movement, are what give any recovery compound something to amplify. Movement and recovery are partners; one earns the other.
Restraint matters too. The most experienced people often run remarkably simple regimens, one or two well-chosen compounds, kept steady, observed closely. More compounds mean more variables and less clarity about what is actually working.
Frequently Asked
Which recovery peptides are most studied?
BPC-157 carries the deepest citation record in this family, with TB-500 frequently appearing alongside it in the literature. Polaris Research supplies BPC-157 on its own and as a blended vial with TB-500.
Is the BPC-157 and TB-500 blend better than the single vial?
Neither is better; they answer different questions. A single-compound vial keeps one variable isolated, which is where a study usually starts. The blend suits a later question about how the two behave together.
What else sits in the recovery family?
KPV and Thymosin Alpha 1 are both supplied as 10mg vials and appear in the same broad research area. The comparison table above lists each with its per-milligram price and assay purity.
Compounds Covered
Every order ships free Express Australia-wide, with tracking and support when you need it.
Educational information only. Nothing here is medical advice or a therapeutic claim. Speak with a qualified healthcare professional before beginning any protocol. Last reviewed 23 June 2026.
Independent reading
Our library is introductory research-supply context. When you want published-evidence summaries written for researchers, reptides.co is a useful next step. It is entirely separate from this store.
- Peptide tier list47 peptides ranked S–F by published human evidence — free to browse from the reptides homepage.reptides.co
- MethodologyHow tiers are set, how citations are audited, and how rankings change when trial data moves.reptides.co
- Weight lossEditorial guide to GLP-1 class peptides and related metabolic compounds.reptides.co
- Recovery & injuryHealing-category peptides — what the preclinical and clinical record actually shows.reptides.co
- Skin & anti-agingCopper peptides, blends, and cosmetic-category evidence in one place.reptides.co
- Growth hormone axisSecretagogues, GHRH analogs, and how the evidence stacks up.reptides.co
- Focus & cognitionNootropic peptides — trial history, mechanisms, and where the record is thin.reptides.co
- LongevityMitochondrial peptides, bioregulators, and what is still preclinical.reptides.co
- Peptide market mapSupply chain, testing, pricing context, and regulatory movement — updated quarterly.reptides.co
Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.